Skip to main content

Table 2 The antibiotic sensitivities of A. baumannii isolates and screening results of OXA genes

From: Molecular characterisation and control of Acinetobacter baumanniiisolates resistant to multi-drugs emerging in inter-intensive care units

 

SAM

TZP

CAZ

FEM

AMK

GAT

TOB

NET

CIPX

TGC

CST

SXT

IPM

MEM

Sensitive n (%)

8 (7.3)

3 (2.8)

19 (17.4)

2 (1.7)

19 (17.4)

85 (77.9)

86 (78.9)

93 (85.3)

2 (1.8)

109 (100)

109 (100)

69 (63.3)

7 (6.4)

6 (5.5)

Intermediate n (%)

22 (20.2)

0

7 (6.4)

1 (1.1)

4 (3.7)

3 (2.8)

0

1 (1.0)

0

0

0

0

2 (1.7)

1 (1.0)

Resistant n (%)

79 (72.5)

106 (97.2)

83 (76.2)

106 (97.2)

86 (78.9)

21 (19.3)

23 (21.1)

15 (13.7)

107 (98.2)

0

0

40 (36.7)

100 (91.9)

102 (93.5)

bla OXA-51-like

All isolates (n=109) were positive

bla OXA-23-like

103 of isolates were positive

bla OXA-24-like

All negative

bla OXA-48-like

All negative

bla OXA-58-like

All negative

  1. SAM: Ampicillin-sulbactam, TZP: Piperacillin-tazobactam, CAZ: Ceftazidime, FEM: Cefepime, AMK: Amikacin, GAT: Gentamicin, TOB: Tobramicin, NET: Netilmicin.
  2. TGC: Tigecycline, CIPX(Ciprofloxacin),CST: Colistin, SXT: Trimethoprim-sulphamethoxazole, IPM: Imipenem, MEM: Meropenem.